119 related articles for article (PubMed ID: 28759630)
21. The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Dørum A; Birkeland E; Hveem K; Romundstad P; Vatten L; Lønning PE; Knappskog S
Tumour Biol; 2016 Aug; 37(8):10697-702. PubMed ID: 26867771
[TBL] [Abstract][Full Text] [Related]
22. Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis.
Schwinzer R; Witte T; Hundrieser J; Ehlers S; Momot T; Hunzelmann N; Krieg T; Schmidt RE; Wonigeit K
Genes Immun; 2003 Mar; 4(2):168-9. PubMed ID: 12618866
[TBL] [Abstract][Full Text] [Related]
23. CD45 (PTPRC) as a candidate gene in multiple sclerosis.
Vyshkina T; Leist TP; Shugart YY; Kalman B
Mult Scler; 2004 Dec; 10(6):614-7. PubMed ID: 15584483
[TBL] [Abstract][Full Text] [Related]
24. CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers.
Gomez-Lira M; Liguori M; Magnani C; Bonamini D; Salviati A; Leone M; Andreoli V; Trojano M; Valentino P; Savettieri G; Quattrone A; Pignatti PF; Momigliano-Richiardi P; Giordano M
J Neuroimmunol; 2003 Jul; 140(1-2):216-21. PubMed ID: 12864992
[TBL] [Abstract][Full Text] [Related]
25. Human CD45RC specificity. A novel marker for T cells at different maturation and activation stages.
Zapata JM; Pulido R; Acevedo A; Sánchez-Madrid F; de Landázuri MO
J Immunol; 1994 Apr; 152(8):3852-61. PubMed ID: 8144955
[TBL] [Abstract][Full Text] [Related]
26. No association between transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77C>G) and idiopathic dilated cardiomyopathy.
Thude H; Gerlach K; Richartz B; Krack A; Brenke B; Pethig K; Figulla HR; Barz D
Hum Immunol; 2005 Sep; 66(9):1008-12. PubMed ID: 16360841
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of CD45 isoforms in canine leukocytes.
Goto-Koshino Y; Tomiyasu H; Suzuki H; Tamamoto T; Mizutani N; Fujino Y; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2014 Jul; 160(1-2):118-22. PubMed ID: 24794330
[TBL] [Abstract][Full Text] [Related]
28. Association of R156R single nucleotide polymorphism of the ERCC2 gene with the susceptibility to ovarian cancer.
Romanowicz H; Michalska MM; Samulak D; Malinowski J; Szaflik T; Bieńkiewicz J; Smolarz B
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():36-40. PubMed ID: 27888704
[TBL] [Abstract][Full Text] [Related]
29. A point mutation in PTPRC is associated with the development of multiple sclerosis.
Jacobsen M; Schweer D; Ziegler A; Gaber R; Schock S; Schwinzer R; Wonigeit K; Lindert RB; Kantarci O; Schaefer-Klein J; Schipper HI; Oertel WH; Heidenreich F; Weinshenker BG; Sommer N; Hemmer B
Nat Genet; 2000 Dec; 26(4):495-9. PubMed ID: 11101853
[TBL] [Abstract][Full Text] [Related]
30. Distinct splicing of CD45 mRNA in activated rat gamma delta cytotoxic T lymphocytes.
Hansson J; Dohlsten M; Sjögren HO; Hedlund G
Eur J Immunol; 1995 Jan; 25(1):75-9. PubMed ID: 7843256
[TBL] [Abstract][Full Text] [Related]
31. An analysis of alternatively spliced CD45 mRNA transcripts during T cell maturation in humans.
Ratech H; Denning S; Kaufman RE
Cell Immunol; 1997 May; 177(2):109-18. PubMed ID: 9178637
[TBL] [Abstract][Full Text] [Related]
32. PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients.
Barcellos LF; Caillier S; Dragone L; Elder M; Vittinghoff E; Bucher P; Lincoln RR; Pericak-Vance M; Haines JL; Weiss A; Hauser SL; Oksenberg JR
Nat Genet; 2001 Sep; 29(1):23-4. PubMed ID: 11528386
[TBL] [Abstract][Full Text] [Related]
33. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
Jin X; Kang S; Wang N; Xing YP; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
[TBL] [Abstract][Full Text] [Related]
34. Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.
Ratajska M; Matusiak M; Kuzniacka A; Wasag B; Brozek I; Biernat W; Koczkowska M; Debniak J; Sniadecki M; Kozlowski P; Klonowska K; Pilyugin M; Wydra D; Laurent G; Limon J; Irminger-Finger I
Oncol Rep; 2015 Nov; 34(5):2609-17. PubMed ID: 26329992
[TBL] [Abstract][Full Text] [Related]
35. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
36. Transient accumulation and subsequent rapid loss of messenger RNA encoding high molecular mass CD45 isoforms after T cell activation.
Deans JP; Serra HM; Shaw J; Shen YJ; Torres RM; Pilarski LM
J Immunol; 1992 Mar; 148(6):1898-905. PubMed ID: 1531846
[TBL] [Abstract][Full Text] [Related]
37. Functional significance of the 77C --> G polymorphism in the human CD45 gene: enhanced T-cell reactivity by variantly expressed CD45RA isoforms.
Do HT; Baars W; Schwinzer R
Transplant Proc; 2005; 37(1):51-2. PubMed ID: 15808544
[No Abstract] [Full Text] [Related]
38. E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese.
Li Y; Liang J; Kang S; Dong Z; Wang N; Xing H; Zhou R; Li X; Zhao X
Gynecol Oncol; 2008 Feb; 108(2):409-14. PubMed ID: 18035404
[TBL] [Abstract][Full Text] [Related]
39. CD45 alternative exon expression in murine and human CD4+ T cell subsets.
Rogers PR; Pilapil S; Hayakawa K; Romain PL; Parker DC
J Immunol; 1992 Jun; 148(12):4054-65. PubMed ID: 1351092
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer.
Schüler S; Lattrich C; Skrzypczak M; Fehm T; Ortmann O; Treeck O
Gene; 2014 Aug; 546(2):283-7. PubMed ID: 24881814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
